PECAM1 and colorectal carcinoma: In the high STOML2 expression group, 71.4%, 75.0% and 64.3% of CRC specimens showed high levels of Ki67, CD31 and VEGFC, respectively, whereas 63.6%, 72.7% and 72.7% of specimens with low STOML2 expression exhibited low expression of Ki67, CD31 and VEGFC, respectively (Fig. 7b).